Liu J, Li Y, Wang M, Yang J
World J Virol. 2024; 13(2):91286.
PMID: 38984081
PMC: 11229840.
DOI: 10.5501/wjv.v13.i2.91286.
Damour A, Faure M, Landrein N, Ragues J, Ardah N, Dhaidel H
Vaccines (Basel). 2024; 12(5).
PMID: 38793744
PMC: 11125902.
DOI: 10.3390/vaccines12050493.
Abdelouahed M, Yateem D, Fredericks S
Front Cardiovasc Med. 2023; 10:1282637.
PMID: 38034388
PMC: 10684751.
DOI: 10.3389/fcvm.2023.1282637.
Zhou Z, Li D, Zhao Z, Shi S, Wu J, Li J
PLoS Comput Biol. 2023; 19(9):e1011383.
PMID: 37656752
PMC: 10501599.
DOI: 10.1371/journal.pcbi.1011383.
Hsiao S, Sue Y, Kao C, Chang H, Lin Y, Hung C
Vaccines (Basel). 2023; 11(7).
PMID: 37514977
PMC: 10383458.
DOI: 10.3390/vaccines11071161.
SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic.
Chakraborty C, Bhattacharya M, Dhama K
Vaccines (Basel). 2023; 11(3).
PMID: 36992266
PMC: 10054865.
DOI: 10.3390/vaccines11030682.
The Streptococcus pyogenes vaccine landscape.
Walkinshaw D, Wright M, Mullin A, Excler J, Kim J, Steer A
NPJ Vaccines. 2023; 8(1):16.
PMID: 36788225
PMC: 9925938.
DOI: 10.1038/s41541-023-00609-x.
Identifying COVID-19 optimal vaccine dose using mathematical immunostimulation/immunodynamic modelling.
Rhodes S, Smith N, Evans T, White R
Vaccine. 2022; 40(49):7032-7041.
PMID: 36272876
PMC: 9574467.
DOI: 10.1016/j.vaccine.2022.10.012.
Public attitudes on social media toward vaccination before and during the COVID-19 pandemic.
Shah U, Biswas M, Ali R, Ali H, Shah Z
Hum Vaccin Immunother. 2022; 18(6):2101835.
PMID: 35920771
PMC: 9746453.
DOI: 10.1080/21645515.2022.2101835.
Conjugation with 8-arm PEG and CRM enhances the immunogenicity of SARS-CoV-2 ORF8 protein.
Tang X, Yu W, Shen L, Qi J, Hu T
Int Immunopharmacol. 2022; 109:108922.
PMID: 35687905
PMC: 9168007.
DOI: 10.1016/j.intimp.2022.108922.
Utilizing wearable sensors for continuous and highly-sensitive monitoring of reactions to the BNT162b2 mRNA COVID-19 vaccine.
Gepner Y, Mofaz M, Oved S, Yechezkel M, Constantini K, Goldstein N
Commun Med (Lond). 2022; 2:27.
PMID: 35603274
PMC: 9053261.
DOI: 10.1038/s43856-022-00090-y.
Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan.
Chang J, Chiou J, Hung C, Liu M, Chang H, Hong S
Vaccines (Basel). 2022; 10(2).
PMID: 35214770
PMC: 8874464.
DOI: 10.3390/vaccines10020312.
Robust validation and performance comparison of immunogenicity assays assessing IgG and neutralizing antibodies to SARS-CoV-2.
Bonhomme M, Bonhomme C, Strelow L, Chaudhari A, Howlett A, Breidenbach C
PLoS One. 2022; 17(2):e0262922.
PMID: 35130298
PMC: 8820625.
DOI: 10.1371/journal.pone.0262922.
Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses.
Napolitano V, Dabrowska A, Schorpp K, Mourao A, Barreto-Duran E, Benedyk M
Cell Chem Biol. 2022; 29(5):774-784.e8.
PMID: 35021060
PMC: 8751734.
DOI: 10.1016/j.chembiol.2021.11.006.
Clinical Cardiovascular Adverse Events Reported Post-COVID-19 Vaccination: Are They a Real Risk?.
Hana D, Patel K, Roman S, Gattas B, Sofka S
Curr Probl Cardiol. 2021; 47(3):101077.
PMID: 34902392
PMC: 8662957.
DOI: 10.1016/j.cpcardiol.2021.101077.
Vaccine-Associated Disease Enhancement (VADE): Considerations in Postvaccination COVID-19.
Tunjungputri R, Tetrasiwi E, Veronica M, Pandelaki J, Ibrahim F, Nelwan E
Case Rep Med. 2021; 2021:9673453.
PMID: 34745267
PMC: 8570879.
DOI: 10.1155/2021/9673453.
Nanoparticle approaches against SARS-CoV-2 infection.
Duan Y, Wang S, Zhang Q, Gao W, Zhang L
Curr Opin Solid State Mater Sci. 2021; 25(6):100964.
PMID: 34729031
PMC: 8542438.
DOI: 10.1016/j.cossms.2021.100964.
SARS-CoV-2 immunity and functional recovery of COVID-19 patients 1-year after infection.
Zhan Y, Zhu Y, Wang S, Jia S, Gao Y, Lu Y
Signal Transduct Target Ther. 2021; 6(1):368.
PMID: 34645784
PMC: 8512652.
DOI: 10.1038/s41392-021-00777-z.
Point-of-care COVID-19 diagnostics powered by lateral flow assay.
Zhou Y, Wu Y, Ding L, Huang X, Xiong Y
Trends Analyt Chem. 2021; 145:116452.
PMID: 34629572
PMC: 8487324.
DOI: 10.1016/j.trac.2021.116452.
COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.
Pearson C, Bozzani F, Procter S, Davies N, Huda M, Jensen H
PLoS Med. 2021; 18(10):e1003815.
PMID: 34606520
PMC: 8523052.
DOI: 10.1371/journal.pmed.1003815.
